Literature DB >> 7684396

Relative expression of insulin receptor isoforms does not differ in lean, obese, and noninsulin-dependent diabetes mellitus subjects.

C M Anderson1, R R Henry, P E Knudson, J M Olefsky, N J Webster.   

Abstract

The insulin receptor is expressed as two isoforms that differ by a 12-amino acid region at the carboxy-terminus of the alpha-subunit encoded by exon 11. These isoforms are produced by tissue-specific alternate splicing of the insulin receptor mRNA. To determine whether the relative expression of the isoforms is altered in skeletal muscle in two insulin-resistant states, NIDDM and obesity, relative mRNA levels were measured using a polymerase chain reaction technique. There were no differences in the relative amounts of skeletal muscle mRNA encoding the exon 11-containing form compared to the exon 11-lacking form of the insulin receptor among lean normal (30 +/- 2% Ex11-), obese nondiabetic (32 +/- 2%), and NIDDM (31 +/- 1%) subjects. We conclude that altered expression of insulin receptor isoform mRNAs does not account for skeletal muscle insulin resistance in NIDDM and obesity.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7684396     DOI: 10.1210/jcem.76.5.7684396

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  11 in total

Review 1.  Tissue barriers and novel approaches to achieve hepatoselectivity of subcutaneously-injected insulin therapeutics.

Authors:  Juntang Shao; Jennica L Zaro; Wei-Chiang Shen
Journal:  Tissue Barriers       Date:  2016-03-04

2.  Tissue-specific expression of two alternatively spliced isoforms of the human insulin receptor protein.

Authors:  G Sesti; A N Tullio; R D'Alfonso; M L Napolitano; M A Marini; P Borboni; R Longhi; L Albonici; A Fusco; A M Aglianò
Journal:  Acta Diabetol       Date:  1994-06       Impact factor: 4.280

3.  Development of a Quantitative PCR Assay for Detection of Human Insulin-Like Growth Factor Receptor and Insulin Receptor Isoforms.

Authors:  Clare A Flannery; Anne M Rowzee; Gina H Choe; Farrah L Saleh; Caitlin C Radford; Hugh S Taylor; Teresa L Wood
Journal:  Endocrinology       Date:  2016-02-10       Impact factor: 4.736

4.  Increased expression of low-affinity insulin receptor isoform and insulin/insulin-like growth factor-I hybrid receptors in term placenta from insulin-resistant women with gestational hypertension.

Authors:  H Valensise; Y Y Liu; M Federici; D Lauro; D Dell'anna; C Romanini; G Sesti
Journal:  Diabetologia       Date:  1996-08       Impact factor: 10.122

5.  Peptide-based radioimmunoassay for the two isoforms of the human insulin receptor.

Authors:  G Sesti; R D'Alfonso; M D Vargas Punti; L Frittitta; V Trischitta; Y Y Liu; P Borboni; R Longhi; A Montemurro; R Lauro
Journal:  Diabetologia       Date:  1995-04       Impact factor: 10.122

6.  Chronic primary hyperinsulinaemia is associated with altered insulin receptor mRNA splicing in muscle of patients with insulinoma.

Authors:  P Sbraccia; M D'Adamo; F Leonetti; S Caiola; P Iozzo; A Giaccari; A Buongiorno; G Tamburrano
Journal:  Diabetologia       Date:  1996-02       Impact factor: 10.122

7.  Pioglitazone prevents obesity-related airway hyperreactivity and neuronal M2 receptor dysfunction.

Authors:  Becky J Proskocil; Allison D Fryer; David B Jacoby; Zhenying Nie
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2021-05-19       Impact factor: 6.011

8.  Insulin receptor membrane retention by a traceable chimeric mutant.

Authors:  Jimena Giudice; Elizabeth A Jares-Erijman; Federico Coluccio Leskow
Journal:  Cell Commun Signal       Date:  2013-06-27       Impact factor: 5.712

Review 9.  Brain pathology in myotonic dystrophy: when tauopathy meets spliceopathy and RNAopathy.

Authors:  Marie-Laure Caillet-Boudin; Francisco-Jose Fernandez-Gomez; Hélène Tran; Claire-Marie Dhaenens; Luc Buee; Nicolas Sergeant
Journal:  Front Mol Neurosci       Date:  2014-01-09       Impact factor: 5.639

10.  Aberrant liver insulin receptor isoform a expression normalises with remission of type 2 diabetes after gastric bypass surgery.

Authors:  Vinko Besic; Hongjun Shi; Richard S Stubbs; Mark T Hayes
Journal:  PLoS One       Date:  2015-03-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.